(Press-News.org)
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive form of leukemia that arises from the malignant transformation of T-cell progenitors. This disease is most commonly diagnosed in children, where it accounts for a significant portion of pediatric leukemia cases, but it also affects adults. The clinical presentation of T-ALL includes symptoms resulting from bone marrow failure, such as anemia, thrombocytopenia, and neutropenia, as well as symptoms due to extramedullary disease, including lymphadenopathy, splenomegaly, and mediastinal masses. Despite improvements in treatment protocols, which have led to higher remission rates, the prognosis for T-ALL remains challenging due to high rates of relapse, particularly in adult patients.
T-ALL pathogenesis involves a series of genetic and epigenetic changes that disrupt normal T-cell development and lead to uncontrolled proliferation. Central to these changes are alterations in the expression and function of key transcription factors that regulate T-cell differentiation and proliferation. One such transcription factor is TAL1 (T-cell acute lymphoblastic leukemia 1), also known as SCL (stem cell leukemia). TAL1 is essential for the development of hematopoietic cells and is aberrantly expressed in a significant subset of T-ALL cases. The inappropriate expression of TAL1 in T-cell progenitors leads to a block in differentiation and promotes leukemogenesis.
TAL1 is normally involved in early hematopoiesis and is crucial for the development of erythroid and megakaryocytic lineages. In the context of T-ALL, however, TAL1 expression is frequently dysregulated due to chromosomal rearrangements or mutations. This ectopic expression of TAL1 interferes with the normal transcriptional programs of T-cells and leads to leukemic transformation. TAL1 exerts its oncogenic effects by altering the expression of a variety of target genes, including those involved in cell cycle regulation, apoptosis, and cell adhesion.
One of the key mechanisms through which TAL1 promotes T-ALL is by modulating the expression of microRNAs (miRNAs). MiRNAs are small non-coding RNAs that regulate gene expression post-transcriptionally and play crucial roles in various cellular processes, including differentiation, proliferation, and apoptosis. In T-ALL, TAL1 has been shown to downregulate specific miRNAs that act as tumor suppressors. Among these, miR-146b-5p has emerged as a critical player.
MiR-146b-5p is a tumor suppressor miRNA that is highly expressed in normal single-positive thymocytes. It regulates the expression of genes involved in cell migration and invasion, processes that are crucial for the metastatic potential of cancer cells. In T-ALL, the downregulation of miR-146b-5p by TAL1 leads to the upregulation of its target genes, which include those involved in cell motility and invasion. This dysregulation enhances the invasive properties of T-ALL cells, facilitating their spread to various tissues.
The loss of miR-146b-5p expression has been associated with increased aggressiveness of T-ALL and poor prognosis. By targeting the TAL1-miR-146b-5p axis, researchers aim to develop new therapeutic strategies that can limit the spread of leukemia cells and improve patient outcomes. Restoring the expression of miR-146b-5p or inhibiting the pathways activated by its loss could potentially reduce the invasive and migratory capabilities of T-ALL cells.
The development and progression of T-ALL involve a complex interplay of genetic and epigenetic factors. The TAL1 transcription factor plays a central role in this process by dysregulating the expression of key genes and miRNAs, including the tumor suppressor miR-146b-5p. Understanding the molecular mechanisms underlying TAL1-mediated leukemogenesis provides valuable insights into the pathogenesis of T-ALL and identifies potential targets for therapeutic intervention.
Future research should focus on elucidating the upstream regulatory mechanisms that control TAL1 expression and its downstream targets, as well as exploring the therapeutic potential of modulating the TAL1-miR-146b-5p axis. Such efforts could lead to the development of novel treatments that improve the prognosis for patients with this aggressive form of leukemia.
Full text
https://www.xiahepublishing.com/1555-3884/GE-2023-00076
The study was recently published in the Gene Expression.
Gene Expression (GE) is an open-access journal. It was launched in 1991 by Chicago Medical School Press, and transferred to Cognizant Communication Corporation in 1994. From August 2022, GE is published by Xia & He Publishing Inc.
GE publishes peer-reviewed and high-quality original articles, reviews, editorials, commentaries, and opinions on its primary research topics including cell biology, molecular biology, genes, and genetics, especially on the cellular and molecular mechanisms of human diseases.
GE has been indexed in Medline (1991-2021), Scopus, Biological Abstracts, Biosis Previews, ProQuest, etc.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
(Toronto, July 23, 2024) JMIR Publications invites submissions to a new theme issue titled “First Look: Early Research, Viewpoints, and Experiences with Apple Vision Pro in Health Care Settings” in its new open access journal JMIR XR and Spatial Computing.
This theme issue aims to gather early research findings, diverse and critical viewpoints, and real-world experiences concerning the utilization of Apple Vision Pro in health care contexts. We invite contributions that explore the following topics:
Medical education ...
Every year in the United States, an estimated 476,000 people are diagnosed and treated for Lyme disease. The estimate comes from the U.S. Centers for Disease Control and Prevention (CDC).
Lyme disease can be treated with antibiotics. The best health outcomes are most likely when diagnosis is made within the first weeks of infection. If left untreated, the effects of Lyme disease can linger for years and cause neurological problems, arthritis, and a host of other ailments. But because diagnosing ...
Breast cancer (BC) remains one of the most challenging cancers to treat, primarily due to its heterogeneity and propensity for metastasis. The Notch signaling pathway is integral to various cellular processes and has been implicated in the development and progression of BC. NcRNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), have emerged as pivotal regulators of gene expression, affecting cancer biology through their interactions with the Notch pathway.
Non-coding ...
Since the laser was invented in the 1960s, scientists have been working to increase lasers’ peak power and to design machines producing coherent light at progressively shorter wavelengths that can improve image resolution and enable probing of quantum nuclear states.
Progress has been made with regard to peak power, most notably with the invention of chirped pulse amplification by University of Rochester researchers in the 1980s, a breakthrough that garnered the Nobel Prize in Physics in 2018. However, developing ...
A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research from the University of Illinois Chicago.
For a new paper in Nature Chemical Biology, researchers probed how a class of synthetic drugs called macrolones disrupt bacterial cell function to fight infectious diseases. Their experiments demonstrate that macrolones can work two different ways – either by interfering with protein production or corrupting DNA structure.
Because bacteria would need to implement ...
LA JOLLA (July 23, 2024)—Salk Professor Janelle Ayres has been selected as a 2024 Howard Hughes Medical Institute (HHMI) Investigator. The HHMI Investigators program awards established scientists with approximately $9 million in funding over seven years to pursue boundary-breaking research in their field. The honor recognizes her influential work in immunology and microbiology and its applications to the global crisis of antibiotic resistance.
Ayres is among 26 other 2024 selectees, who will join more than 250 standing Investigators—including Salk Professors ...
INDIANAPOLIS -- The National Library of Medicine has awarded Regenstrief Institute a five-year, $5 million contract extension to ensure the continued maintenance, expansion and public distribution of LOINC®, a global standard for health terminology. The NLM issued its initial contract to support the creation and development of LOINC in 1999. With this extension, NLM's commitment to LOINC will reach 30 years by the time the award expires in 2029.
“The NLM’s continued support of LOINC demonstrates the value the standard delivers to patients, care providers, health ...
Dr. Jaeyeon Pyo’s team at the Korea Electrotechnology Research Institute (KERI) has become the first in the world to reveal light emission patterns from 3D-printed nanowires, which has been published as a cover article in the prestigious scientific journal ACS Nano.
The higher resolution in display devices signifies the more of pixels in a given screen size. As pixel density increases, movies and images are displayed with greater precision and detail. In this regard, ongoing research aims to fabricate ...
The Howard Hughes Medical Institute announced on July 23, 2024 that 26 of the nation’s leading scientists have been named HHMI Investigators.
Paving the way for new scientific and biomedical discoveries in fields ranging from neuroscience to immunology to structural biology, these scientists come from 19 US institutions and join HHMI’s current Investigator community, comprising more than 250 scientists.
HHMI will invest more than $300 million in this newest cohort over the next seven years, enabling each Investigator to push the boundaries of science.
“HHMI is committed to supporting visionary scientists who are pursuing discoveries that will change ...
High blood pressure is known to increase a person’s chances of having a stroke.
But a study led by Michigan Medicine narrows in on the cumulative effects of years of high systolic blood pressure — the top number on the blood pressure reading and how hard the heart pumps blood to the arteries — finding that a higher average reading during adulthood is linked with a greater risk for the two most common types of stroke.
The study, published in JAMA Network Open, analyzed the average systolic blood pressure years ahead of the first stroke for more than 40,000 people ...
